A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report

The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-line treatment option for people who cannot tolerate platinum. Immunotherapy is pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianzheng, Li, Qingli, Lv, Huifang, Nie, Caiyun, Chen, Beibei, Xu, Weifeng, Yang, Tiejun, Zhang, Yinping, Tu, Shuiping, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249845/
https://www.ncbi.nlm.nih.gov/pubmed/34221988
http://dx.doi.org/10.3389/fonc.2021.671416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249845/
https://www.ncbi.nlm.nih.gov/pubmed/34221988
http://dx.doi.org/10.3389/fonc.2021.671416

Ejemplares similares